Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Waterslide malfunction on Royal Caribbean's Icon of the Seas injures passenger, prompting investigation.
Authorities search for two missing women in separate incidents in Southern California, heightening urgency due to vulnerable conditions surrounding their disappearances.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Waterslide malfunction on Royal Caribbean's Icon of the Seas injures passenger, prompting investigation.
Authorities search for two missing women in separate incidents in Southern California, heightening urgency due to vulnerable conditions surrounding their disappearances.